Evaluation of a manualised neurofeedback training in psychosomatic-psychotherapeutic outpatient treatment (Neuro-pp-out): study protocol for a clinical mixed-methods pilot study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 Apr 2024
Historique:
medline: 19 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: epublish

Résumé

Electroencephalographic neurofeedback (NFB), as a non-invasive form of brainwave training, has been shown to be effective in the treatment of various mental health disorders. However, only few results regarding manualised and standardised NFB trainings exist. This makes comparison as well as replication of studies difficult. Therefore, we developed a standard manual for NFB training in patients with mental health disorders attending a psychosomatic outpatient clinic. The current study aims at investigating the conduction of a standardised manual for NFB training in patients with mental health disorders. If successful, the study provides new opportunities to investigate NFB in a more controlled and comparable manner in clinical practice. 30 patients diagnosed with a mental health disorder will be included. After the educational interview, patients will undergo baseline diagnostics (T0). The subsequent intervention consists of 10 sessions of NFB training aiming at increasing sensorimotor rhythm and alpha-frequency amplitudes and decreasing theta-frequency and high beta-frequency amplitudes to induce relaxation and decrease subjective stress. All patients will undergo a post-treatment diagnostic assessment (T1) and a follow-up assessment 8 weeks following the closing session (T2). Changes in amplitude bands (primary outcome) will be recorded with electroencephalography during pre-assessments, post-assessments and follow-up assessments and during NFB sessions. Physiological (respiratory rate, blood volume pulse, muscle tension) and psychometric parameters (distress, perceived stress, relaxation ability, depressive and anxiety symptoms, insomnia, self-efficacy and quality of life) will be assessed at T0, T1 and T2. Moreover, satisfaction, acceptance and usability will be assessed at T1 after NFB training. Further, qualitative interviews about the experiences with the intervention will be conducted with NFB practitioners 6 months after the study starts. Quantitative data will be analysed using repeated measures analysis of variance as well as mediation analyses on mixed linear models. Qualitative data will be analysed using Mayring's content analysis. The study was approved by the ethics committee of the Medical Faculty of the University of Duisburg-Essen (23-11140-BO) and patient enrolment began in April 2023. Before participation, written informed consent by each participant will be required. Results will be published in peer-reviewed journals and conference presentations. Prospectively registered on 28 March 2023 in the German clinical trials register, DRKS00031497.

Identifiants

pubmed: 38631828
pii: bmjopen-2023-079098
doi: 10.1136/bmjopen-2023-079098
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e079098

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: Author AK is employed by NeuroFit GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

Références

Addiction. 2002 Sep;97(9):1123-35
pubmed: 12199828
Pharmacol Biochem Behav. 1989 Jan;32(1):9-15
pubmed: 2734355
Brain. 2020 Jun 1;143(6):1674-1685
pubmed: 32176800
Trauma Violence Abuse. 2020 Jul;21(3):541-550
pubmed: 29890906
Healthcare (Basel). 2021 Oct 11;9(10):
pubmed: 34683031
Psychol Trauma. 2020 Nov;12(8):918-929
pubmed: 32658503
Integr Cancer Ther. 2015 Jul;14(4):318-40
pubmed: 25716351
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Brain Sci. 2022 Jun 17;12(6):
pubmed: 35741679
Neurophysiol Clin. 2015 Dec;45(6):423-33
pubmed: 26553293
Neurotherapeutics. 2012 Jul;9(3):569-87
pubmed: 22814935
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Psychother Psychosom. 2016;85(5):262-9
pubmed: 27509065
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
J Ment Health. 2012 Aug;21(4):346-54
pubmed: 22315961
Sci Rep. 2022 Sep 29;12(1):16341
pubmed: 36175459
Appl Psychophysiol Biofeedback. 2023 Jun;48(2):217-227
pubmed: 36401150
J Affect Disord. 2019 Oct 1;257:287-296
pubmed: 31302517
Psychother Psychosom Med Psychol. 1989 Jul;39(7):248-55
pubmed: 2762479
Basic Clin Neurosci. 2016 Apr;7(2):143-58
pubmed: 27303609
Neuropsychobiology. 1993;28(1-2):76-81
pubmed: 8255414
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Neurosci Biobehav Rev. 2015 Jul;54:29-37
pubmed: 25862940
Am J Psychiatry. 2013 Mar;170(3):275-89
pubmed: 23360949

Auteurs

Kira Leandra Schmidt (KL)

Department for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Nordrhein-Westfalen, Germany kira.schmidt@lvr.de.
Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.

Axel Kowalski (A)

NeuroFit GmbH, Kempen, Germany.

Adam Schweda (A)

Department for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Nordrhein-Westfalen, Germany.
Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.

Nora Dörrie (N)

Department for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Nordrhein-Westfalen, Germany.
Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.

Eva Maria Skoda (EM)

Department for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Nordrhein-Westfalen, Germany.
Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.

Alexander Bäuerle (A)

Department for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Nordrhein-Westfalen, Germany.
Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.

Martin Teufel (M)

Department for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Nordrhein-Westfalen, Germany.
Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH